Topoisomerase inhibitors suppressed lithocholic acid-induced promotion of transformation in BALB/3T3.
Kaneko
M
M
Biophysics Division, National Cancer Center Research Institute, Tokyo, Japan.
Horikoshi
J
J
D000818:Animals; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000187:drug effects*; D005347:Fibroblasts; D008095:Lithocholic Acid / Q000037:antagonists & inhibitors*; D008748:Methylcholanthrene; D051379:Mice; D009268:Nalidixic Acid / Q000494:pharmacology*; D010093:Oxolinic Acid / Q000494:pharmacology*; D059004:Topoisomerase I Inhibitors
D059004:Topoisomerase I Inhibitors; D009268:Nalidixic Acid; D008748:Methylcholanthrene; D008095:Lithocholic Acid; D010093:Oxolinic Acid